1. Home
  2. NTRA vs CTRA Comparison

NTRA vs CTRA Comparison

Compare NTRA & CTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CTRA
  • Stock Information
  • Founded
  • NTRA 2003
  • CTRA 1989
  • Country
  • NTRA United States
  • CTRA United States
  • Employees
  • NTRA N/A
  • CTRA N/A
  • Industry
  • NTRA Medical Specialities
  • CTRA Oil & Gas Production
  • Sector
  • NTRA Health Care
  • CTRA Energy
  • Exchange
  • NTRA Nasdaq
  • CTRA Nasdaq
  • Market Cap
  • NTRA 20.9B
  • CTRA 18.8B
  • IPO Year
  • NTRA 2015
  • CTRA 1990
  • Fundamental
  • Price
  • NTRA $158.25
  • CTRA $24.98
  • Analyst Decision
  • NTRA Strong Buy
  • CTRA Strong Buy
  • Analyst Count
  • NTRA 17
  • CTRA 19
  • Target Price
  • NTRA $183.00
  • CTRA $33.33
  • AVG Volume (30 Days)
  • NTRA 1.5M
  • CTRA 8.8M
  • Earning Date
  • NTRA 05-08-2025
  • CTRA 05-05-2025
  • Dividend Yield
  • NTRA N/A
  • CTRA 3.62%
  • EPS Growth
  • NTRA N/A
  • CTRA N/A
  • EPS
  • NTRA N/A
  • CTRA 1.71
  • Revenue
  • NTRA $1,831,000,000.00
  • CTRA $5,802,000,000.00
  • Revenue This Year
  • NTRA $18.39
  • CTRA $48.17
  • Revenue Next Year
  • NTRA $16.72
  • CTRA $7.66
  • P/E Ratio
  • NTRA N/A
  • CTRA $14.18
  • Revenue Growth
  • NTRA 51.50
  • CTRA 9.91
  • 52 Week Low
  • NTRA $92.14
  • CTRA $22.30
  • 52 Week High
  • NTRA $183.00
  • CTRA $29.95
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 53.16
  • CTRA 48.50
  • Support Level
  • NTRA $153.93
  • CTRA $24.24
  • Resistance Level
  • NTRA $165.91
  • CTRA $25.06
  • Average True Range (ATR)
  • NTRA 4.59
  • CTRA 0.54
  • MACD
  • NTRA 0.23
  • CTRA 0.09
  • Stochastic Oscillator
  • NTRA 48.03
  • CTRA 48.50

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CTRA Coterra Energy Inc.

Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.

Share on Social Networks: